000 | 01068 a2200325 4500 | ||
---|---|---|---|
005 | 20250515211814.0 | ||
264 | 0 | _c20100420 | |
008 | 201004s 0 0 fre d | ||
022 | _a0035-3787 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStahl, J P | |
245 | 0 | 0 |
_a[The bacterial meningitides in 2009, the reasons for a consensus conference]. _h[electronic resource] |
260 |
_bRevue neurologique _cSep 2009 |
||
300 |
_aF217-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aBrain Damage, Chronic _xepidemiology |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aConsensus Development Conferences as Topic |
650 | 0 | 4 |
_aDexamethasone _xtherapeutic use |
650 | 0 | 4 |
_aFrance _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aMeningitis, Bacterial _xdiagnosis |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aVaccination |
773 | 0 |
_tRevue neurologique _gvol. 165 Spec No 3 _gp. F217-9 |
|
999 |
_c19588584 _d19588584 |